These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 965092)

  • 21. Evidence that subunits of type A botulinum toxin need not be linked by disulfide.
    Bhattacharyya SD; Sugiyama H; Rust P; Lacey D
    Toxicon; 1988; 26(9):817-25. PubMed ID: 3201486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
    Giménez JA; Sugiyama H
    Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex.
    Sagane Y; Watanabe T; Kouguchi H; Sunagawa H; Obata S; Oguma K; Ohyama T
    Biochem Biophys Res Commun; 2002 Mar; 292(2):434-40. PubMed ID: 11906181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dichain structure of botulinum neurotoxin: identification of cleavage sites in types C, D, and F neurotoxin molecules.
    Sagane Y; Watanabe T; Kouguchi H; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
    J Protein Chem; 1999 Nov; 18(8):885-92. PubMed ID: 10839626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of a protease from Clostridium botulinum type A that nicks single-chain type A botulinum neurotoxin into the di-chain form.
    Dekleva ML; Dasgupta BR
    J Bacteriol; 1990 May; 172(5):2498-503. PubMed ID: 2185224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single chain and dichain forms of neurotoxin in type F Clostridium botulinum culture.
    DasGupta BR; Sugiyama H
    Toxicon; 1977; 15(5):466-71. PubMed ID: 906033
    [No Abstract]   [Full Text] [Related]  

  • 27. Clostridium botulinum type E toxin: effect of pH and method of purification on molecular weight.
    Sacks HS; Covert SV
    Appl Microbiol; 1974 Sep; 28(3):374-82. PubMed ID: 4609265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of diethylpyrocarbonate on the biological activities of botulinum neurotoxin types A and E.
    Dasgupta BR; Rasmussen S
    Arch Biochem Biophys; 1984 Jul; 232(1):172-8. PubMed ID: 6430237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium botulinum type D neurotoxin: purification and detection.
    De Jongh KS; Schwartzkoff CL; Howden ME
    Toxicon; 1989; 27(2):221-8. PubMed ID: 2655181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of toxin complex produced by a unique strain of Clostridium botulinum serotype D 4947.
    Hasegawa K; Watanabe T; Sato H; Sagane Y; Mutoh S; Suzuki T; Yamano A; Kouguchi H; Takeshi K; Kamaguchi A; Fujinaga Y; Oguma K; Ohyama T
    Protein J; 2004 Aug; 23(6):371-8. PubMed ID: 15517984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin.
    Prabakaran S; Tepp W; DasGupta BR
    Toxicon; 2001 Oct; 39(10):1515-31. PubMed ID: 11478959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and molecular size of Clostridium botulinum type C toxin.
    Syuto B; Kubo S
    Appl Environ Microbiol; 1977 Feb; 33(2):400-5. PubMed ID: 403861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium butyricum neurotoxin: partial amino acid sequence of major proteolytic fragments and intracellular activity in PC12 cells.
    Giménez J; Lomneth R; DasGupta BR
    Toxicon; 1994 Sep; 32(9):1137-46. PubMed ID: 7801349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial amino acid sequences of the heavy and light chains of botulinum neurotoxin type E.
    Sathyamoorthy V; DasGupta BR
    Biochem Biophys Res Commun; 1985 Mar; 127(3):768-72. PubMed ID: 3985955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes.
    Evans DM; Williams RS; Shone CC; Hambleton P; Melling J; Dolly JO
    Eur J Biochem; 1986 Jan; 154(2):409-16. PubMed ID: 3753681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F.
    Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1977 Aug; 30(4):179-90. PubMed ID: 20527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and properties of Clostridium botulinum type F toxin.
    Yang KH; Sugiyama H
    Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of Clostridium botulinum type B toxin by an endogenous enzyme.
    DasGupta BR
    J Bacteriol; 1971 Dec; 108(3):1051-7. PubMed ID: 4945183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular diversity of neurotoxins from Clostridium botulinum type D strains.
    Moriishi K; Syuto B; Kubo S; Oguma K
    Infect Immun; 1989 Sep; 57(9):2886-91. PubMed ID: 2668193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813.
    Terajima J; Syuto B; Ochanda JO; Kubo S
    Infect Immun; 1985 May; 48(2):312-7. PubMed ID: 3988338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.